Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone Palmitate in Schizophrenia with Violence Risk
NCT03080194Phase 4Unknown
- Start
- Apr 2017
- Primary completion
- Apr 2018
- Modality
- Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of paliperidone palmitate in schizophrenia. Status: unknown.
02
Drugs
paliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03080194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080194.